IceCure Medical (NasdaqCM:ICCM) Earnings Call Presentation

ProSense® is the first and only medical device to be granted U.S. FDA marketing authorization for the local treatment of low-risk breast cancer with endocrine therapy (Nasdaq: ICCM) icecure-medical.com March 2026 Confidential Forward Looking Statements This presentation contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, as amended, and other Federal securities laws. Words such as "expects," "anticipates," "intends," ...